Author:
Torrance G.W.,Raynauld J.P.,Walker V.,Goldsmith C.H.,Bellamy N.,Band P.A.,Schultz M.,Tugwell P.
Subject
Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology
Reference30 articles.
1. Synvisc Hylan G-F 20 US label
2. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results;Raynauld;Osteoarthritis Cart,2002
3. Guidelines for Economic Evaluation of Pharmaceuticals: Canada,1997
4. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee: including major submissions involving economic analyses,1995
5. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine;Weinstein;JAMA,1996
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献